Rapivab provides the assurance of a full course of flu treatment in the hospital emergency department (ED), urgent care center, or clinic.4
Almost one-third of patients stop taking their medicine earlier than instructed.2
Medication adherence is also a challenge in children. Some barriers to adherence in children include inaccurate dose measurements of an oral suspension, misunderstanding of administration instructions, or forgetfulness of the parent or caregiver. The use of non-oral routes of medication administration can add to possible barriers to adherence. For example, inhaled medications pose additional issues such as inadequate technique or difficult administration.5
Rapivab’s single IV dose guarantees compliance.
65+ compliance concerns
Rapivab may help ensure treatment compliance despite forgetfulness, dementia, Alzheimer’s, or polypharmacy.
Instead of a trip to the pharmacy and multicourse or multiday therapy, patients may prefer a single 15- to 30-minute intravenous (IV) infusion.4